Tag: Capricor Therapeutics

Shares of Capricor Therapeutics are undergoing a reassessment by market experts, reflecting a shift in sentiment. The biotech firm's stock, ...

The shares of biotech firm Capricor Therapeutics have become a pure speculative instrument, with their fate entirely dependent on the ...

A biotechnology firm finds itself caught between groundbreaking scientific progress and significant market headwinds. Capricor Therapeutics is currently experiencing the ...

Capricor Therapeutics finds itself navigating turbulent waters as a federal securities class action lawsuit casts uncertainty over the company's future. ...

Investors showed renewed confidence in Capricor Therapeutics last week following a significant regulatory development from the U.S. Food and Drug ...

Shares of Capricor Therapeutics experienced a significant 10% surge yesterday, closing at $6.79. This substantial gain was driven by a ...

Capricor Therapeutics finds itself at a critical juncture, with its shares embodying a stark contrast between ambitious analyst projections and ...

Investors seeking to lead a securities class action against Capricor Therapeutics must file their motions by September 15. This legal ...

The fate of Capricor Therapeutics now hinges on a high-stakes regulatory confrontation. The biotechnology firm is engaged in a significant ...